Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)

ClinicalTrials.gov ID: NCT03168334

Public ClinicalTrials.gov record NCT03168334. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 3:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-123 Lotion and IDP-123 Vehicle Lotion in the Treatment of Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, efficacy, and tolerability of IDP-123 Lotion in comparison with IDP-123 Vehicle Lotion.

Study identification

NCT ID
NCT03168334
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
801 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 10, 2017
Primary completion
Jul 23, 2018
Completion
Jul 23, 2018
Last update posted
Mar 31, 2021

2017 – 2018

United States locations

U.S. sites
41
U.S. states
21
U.S. cities
39
Facility City State ZIP Site status
Valeant Site 41 Mobile Alabama 36608
Valeant Site 22 Rogers Arkansas 72758
Valeant Site 34 Carlsbad California 92008
Valeant Site 12 Fremont California 94538
Valeant Site 06 San Diego California 92123
Valeant Site 13 San Diego California 92123
Valeant Site 31 San Diego California 92123
Valeant Site 36 Santa Ana California 92701
Valeant Site 25 Denver Colorado 80220
Valeant Site 05 Boynton Beach Florida 33437
Valeant Site 29 Clearwater Florida 33761
Valeant Site 38 Jupiter Florida 33458
Valeant Site 02 Miami Florida 33144
Valeant Site 26 West Palm Beach Florida 33406
Valeant Site 44 Snellville Georgia 30078
Valeant Site 32 Louisville Kentucky 40241
Valeant Site 19 Rockville Maryland 20850
Valeant Site 08 Bay City Michigan 48706
Valeant Site 30 Clarkston Michigan 48346
Valeant Site 37 Clinton Township Michigan 48038
Valeant Site 20 Fort Gratiot Michigan 48059
Valeant Site 24 Fridley Minnesota 55432
Valeant Site 03 Morristown New Jersey 07960
Valeant Site 42 Albuquerque New Mexico 87106
Valeant Site 10 New York New York 10155
Valeant Site 43 Rochester New York 14623
Valeant Site 33 Stony Brook New York 11790
Valeant Site 11 Oklahoma City Oklahoma 73112
Valeant Site 28 Broomall Pennsylvania 19008
Valeant Site 16 Warwick Rhode Island 02886
Valeant Site 18 Knoxville Tennessee 37922
Valeant Site 14 Murfreesboro Tennessee 37130
Valeant Site 23 College Station Texas 77845
Valeant Site 07 Dallas Texas 75234
Valeant Site 27 Pflugerville Texas 78660
Valeant Site 04 San Antonio Texas 78218
Valeant Site 39 Sugar Land Texas 77479
Valeant Site 09 Layton Utah 84041
Valeant Site 15 West Jordan Utah 84088
Valeant Site 21 Charlottesville Virginia 22911
Valeant Site 35 Walla Walla Washington 99362

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03168334, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 31, 2021 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03168334 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →